Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Tue Nov 12, 6:00AM CST

TCRX : 3.94 (-4.37%)
TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition GlobeNewswire - Tue Nov 5, 8:15AM CST

TCRX : 3.94 (-4.37%)
TScan Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 39th Annual Meeting GlobeNewswire - Fri Oct 4, 8:05AM CDT

TCRX : 3.94 (-4.37%)
Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults Newswire.ca - Tue May 28, 12:24PM CDT

/CNW/ -- USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale...

ONCY : 0.9800 (-1.85%)
TCRX : 3.94 (-4.37%)
BMY : 58.23 (+0.60%)
PDSB : 2.20 (+8.64%)
CCCC : 4.01 (-0.99%)
ONC.TO : 1.37 (-2.14%)
Global Efforts Intensify to Address Surging Young Adult Colorectal and Anal Cancer Rates BayStreet.ca - Wed Feb 14, 8:31AM CST

USA News Group – Rates of cancer of the colorectal and anal regions have been on the rise for years in young adults, according to surgeons at Yale Medicine. As well, there are now alarming reports around...

ONCY : 0.9800 (-1.85%)
ONC.TO : 1.37 (-2.14%)
TCRX : 3.94 (-4.37%)
BMY : 58.23 (+0.60%)
PDSB : 2.20 (+8.64%)
CCCC : 4.01 (-0.99%)
People and teaching - Two Colleagues Talking About Markets
Bump up Your Long Term Portfolio Performance With Low Beta Stocks Barchart - Wed May 17, 2023

In this article, discover how low beta stocks can shimmer in your portfolio!

MSFT : 412.87 (-0.63%)
NERV : 2.21 (+4.25%)
STIX : 0.3000 (-19.14%)
SERA : 6.11 (+1.33%)
TCRX : 3.94 (-4.37%)
NVCT : 4.90 (-3.35%)
TScan Therapeutics (NASDAQ: TCRX) and Amgen (NASDAQ: AMGN) Join Forces to Battle Crohn’s Disease Spotlight Growth - Tue May 9, 2023

TScan Therapeutics, Inc. (NASDAQ: TCRX) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

TCRX : 3.94 (-4.37%)
AMGN : 289.90 (+0.71%)
AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S DISEASE PR Newswire - Tue May 9, 2023

/PRNewswire/ -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan's proprietary...

AMGN : 289.90 (+0.71%)
TCRX : 3.94 (-4.37%)
TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress Globe Newswire - Wed Aug 10, 2022

Phase 1 umbrella trial for hematologic malignancies open for enrollment Publication in Cell further validates use of foundational technology to identify...

TCRX : 3.94 (-4.37%)
TScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference Globe Newswire - Wed Aug 3, 2022

WALTHAM, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...

TCRX : 3.94 (-4.37%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth Barchart - Thu Nov 21, 7:18PM CST
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot